Clinical Trials Logo

Loss of Consciousness clinical trials

View clinical trials related to Loss of Consciousness.

Filter by:
  • None
  • Page 1

NCT ID: NCT04901871 Completed - Clinical trials for Loss of Consciousness

Remimazolam Bolus for General Anesthesia

Start date: May 27, 2021
Phase: Phase 3
Study type: Interventional

It is important to estimate the adequate dose of remimazolam intravenous bolus injection to induce the loss of consciousness. We will determine the ED50 and ED95 of remimazolam intravenous bolus on the loss of consciousness in patients undergoing general anesthesia.

NCT ID: NCT04502550 Recruiting - Parkinson Disease Clinical Trials

Brain Networks and Consciousness

Start date: October 15, 2020
Phase:
Study type: Observational

General anesthesia (GA) is a medically induced state of unresponsiveness and unconsciousness, which millions of people experience every year. Despite its ubiquity, a clear and consistent picture of the brain circuits mediating consciousness and responsiveness has not emerged. Studies to date are limited by lack of direct recordings in human brain during medically induced anesthesia. Our overall hypothesis is that the current model of consciousness, originally proposed to model disorders and recovery of consciousness after brain injury, can be generalized to understand mechanisms of consciousness more broadly. This will be studied through three specific aims. The first is to evaluate the difference in anesthesia sensitivity in patients with and without underlying basal ganglia pathology. Second is to correlate changes in brain circuitry with induction and emergence from anesthesia. The third aim is to evaluate the effects of targeted deep brain stimulation on anesthesia induced loss and recovery of consciousness. This study focuses on experimentally studying these related brain circuits by taking advantage of pathological differences in movement disorder patient populations undergoing deep brain stimulation (DBS) surgery. DBS is a neurosurgical procedure that is used as treatment for movement disorders, such as Parkinson's disease and essential tremor, and provides a mechanism to acquire brain activity recordings in subcortical structures. This study will provide important insight by using human data to shed light on the generalizability of the current model of consciousness. The subject's surgery for DBS will be prolonged by up to 40 minutes in order to record the participant's brain activity and their responses to verbal and auditory stimuli.

NCT ID: NCT02831101 Completed - Clinical trials for Loss of Consciousness

Sufentanil Bispectral Index Elderly

Start date: February 2012
Phase: N/A
Study type: Interventional

We compared BIS values during propofol stepwise induction with or without concomitant sufentanil in patients ≥ 65 years .

NCT ID: NCT02783846 Completed - Clinical trials for Loss of Consciousness

The Effects of Different Doses of Dexmedetomidine on Propofol Requirement for Loss of Consciousness Undergoing Bispectral Index: a Double-blinded, Placebo-controlled Trial

Start date: June 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effects of different dexmedetomidine on the propofol requirement for loss of consciousness undergoing bispectral index.

NCT ID: NCT02125214 Completed - Clinical trials for Loss of Consciousness

Alteration of Temporal Organization of EEG Microstate Sequences During Propofol-induced Loss of Consciousness

Fractal
Start date: January 2014
Phase: N/A
Study type: Interventional

Temporal dynamics of the EEG microstates show scale-free monofractal properties. This means that information is encoded in the same way at different scales. It may be postulated that these monofractal properties of the EEG microstate sequences constitute a necessary prerequisite of consciousness. We postulate that clinical variations of consciousness may also be linked to alterations of fractal properties of EEG microstates.

NCT ID: NCT00143754 Terminated - Hydration Clinical Trials

Effect of Chronic Oral Hydration in Patients With Recurrent Unexplained Syncope

Start date: n/a
Phase: Phase 3
Study type: Interventional

Beneficial effect of chronic hydration with salt supplementation in patients with recurrent unexplained syncope is not established. We sought to determine if chronic oral rehydration with salt supplementation improved the tolerance and hemodynamic responses of patients with unexplained recurrent syncope.